AGENDA
FRIDAY 6TH OCTOBER | |
---|---|
08:00 | Registration and coffee |
Session 1 | |
A thorough understanding of anatomy and tissue planes is paramount to avoiding adverse events. The 3 most common areas of fillers complications - periorbital, lips, and SMAS - are discussed and how to successfully treat them. | |
09:00 | Introduction and welcome - Lee Walker BDS |
09:05 |
Post Hyaluronic acid recurrent eyelid edema: diagnosis, prevention and treatment
|
09:25 |
SMAS: The Neglected Layer
|
09:45 |
A Surgical-Nonsurgical Approach to a Lip Complication
Steve Harris MD
|
10:05 | Panel Discussion/ Q and A |
10:30 | Refreshments and Exhibition |
Session 2 | |
The late and delayed events continue to be challenging to diagnose and treat. This session revisits some basics and unpicks the details of actual cases, to navigate management planning. | |
11:00 | Introduction |
11:05 |
The Genetic Origin of Soft Tissue Fillers Adverse Events
Tom Decates MD PhD
|
11:25 |
Max Fax Rescue
John Blythe MD
|
11:45 |
Abscess - A Case Review from Diagnosis to Resolution
|
12:05 | Panel Discussion/ Q and A |
12:30 | Lunch and Exhibition |
Session 3 | |
Threads have become increasingly popular and adverse events are rarely discussed at meetings. This session covers complications with threads and three different approaches to management. | |
13:30 | Introduction |
13:35 |
Surgical Experience with Thread Brow-Lifting
Greg Bran MD
|
13:55 |
Looking Underneath the Skin: A Sonographic Approach to Thread Complications
Rosa Sigrist MD
|
14:15 |
Thread Lifts: Keeping Within the Lines
|
14:35 | Panel Discussion/ Q and A |
14:55 | Refreshments and Exhibition |
Session 4 | |
For HA fillers, hyaluronidase can reverse most complications. What about non-dissolvable fillers? This session looks at cases with non-HA products and how they were managed. | |
15:25 | Introduction |
15:30 |
Managing an adverse PLLA reaction in HIV related Facial Lipoatrophy during the COVID19 Pandemic: A Complex Case Study
|
15:50 |
CaHA Vascular Adverse Events: Developing a protocol to minimise risk of scarring
|
16:10 |
Complications and Management of Equine Collagen Injections in the Aestheic Field
|
16:30 | Panel Discussion/ Q and A |
17:00 | END |
SATURDAY 7TH OCTOBER | |
---|---|
08:00 | Registration and coffee |
Session 1 | |
Vision loss, whether temporary or permanent remains rare, but potentially catastrophic. Speakers present actual cases and explain the management which succeeded and the mechanisms involved. A new protocol is outlined. | |
09:00 | Introduction |
09:05 |
Published Blindness Reversals after HA filler injection – My own experience and the ANZ Blindness Consensus Paper Recommendations for bedside care in this catastrophic adverse event
|
09:25 |
Delayed Visual Loss of Secondary to Vaso-Occlusive Retinopathy: Sometimes the lights come back on
|
09:45 |
A Case of Blindness - Lessons learned
|
10:05 | Panel Discussion/ Q and A |
10:30 | Refreshments and Exhibition |
Session 2 | |
Hyaluronidase continues to dominate resolving VAE, however, adjunctive treatments can potentially speed recovery and minimize long term complications. | |
11:00 | Introduction |
11:05 |
Necrosis Rescue: Are you Prepared for the Apocalypse?
|
11:25 |
VAE/VO Remedies - Everything other than Hyaluronidase
|
11:45 |
Considering Oxygen Therapy - No pressure
|
12:05 |
When Hyaluronidase hits the headlines
|
12:25 | Panel Discussion/ Q and A |
12:45 | Lunch and Exhibition |
Session 3 | |
Using devices and imaging techniques can assist in the management of aesthetic complications. This section discusses the use of MRI, ultrasound, and energy based devices to ensure optimal outcomes. | |
13:45 | Introduction |
14:05 |
Dermal Filler: X-Ray Vision
Mobin Master MD
|
14:25 |
Devices (and other stuff) to Treat Complications
|
14:45 |
Management of Polycaprolaptone (PCL) Associated Delayed Onset Nodules with the Help of Ultrasound Guided Injections
|
15:05 |
Ultrasound-guided complications - pitfalls and pearls
|
15:25 | Panel Discussion/ Q and A |
15:45 | Refreshments and Exhibition |
Question Time | |
16:05 | Audience questions brought to the panel for discussion |
17:00 | END - Evening Reception |